Association of Serum HMGB2 Levels With In-Stent Restenosis: HMGB2 Promotes Neointimal Hyperplasia in Mice With Femoral Artery Injury and Proliferation and Migration of VSMCs

Autor: Zhu Hui Liu, Yu Hu He, Rui Yan Zhang, Lin Lu, Xiao Xiang Yan, Xiao Qun Wang, Ke Yang, Ying Shen, Wei Feng Shen, Ling Jie Wang, Wen Qi Pan, Zheng Bin Zhu, Feng Hua Ding, Jian Zhang
Rok vydání: 2016
Předmět:
0301 basic medicine
Male
Pathology
Swine
Receptor for Advanced Glycation End Products
Coronary Artery Disease
030204 cardiovascular system & hematology
Coronary Angiography
Muscle
Smooth
Vascular

0302 clinical medicine
Restenosis
Cell Movement
Risk Factors
Phosphorylation
Cells
Cultured

Neointimal hyperplasia
Mice
Knockout

biology
Middle Aged
Femoral Artery
medicine.anatomical_structure
Phenotype
Swine
Miniature

Female
RNA Interference
Stents
Cardiology and Cardiovascular Medicine
Artery
Signal Transduction
medicine.medical_specialty
Myocytes
Smooth Muscle

Transfection
HMGB2
Coronary Restenosis
03 medical and health sciences
Percutaneous Coronary Intervention
Neointima
medicine
Animals
HMGB2 Protein
Humans
Genetic Predisposition to Disease
Femoral artery injury
Aged
Cell Proliferation
Hyperplasia
business.industry
NADPH Oxidases
Vascular System Injuries
medicine.disease
Mice
Inbred C57BL

Disease Models
Animal

030104 developmental biology
Logistic Models
Case-Control Studies
Multivariate Analysis
biology.protein
In stent restenosis
business
Reactive Oxygen Species
Biomarkers
Zdroj: Arteriosclerosis, thrombosis, and vascular biology. 37(4)
ISSN: 1524-4636
Popis: Objective— In a previous study, we established diabetic and nondiabetic minipig models with coronary artery in-stent restenosis (ISR). Mass spectrometry showed that high-mobility group box (HMGB) 2 level was higher in ISR than in non-ISR tissue from diabetic minipigs. We here investigated whether serum HMGB2 levels were related to ISR in coronary artery disease patients. The effect of HMGB2 was evaluated in mice with femoral artery wire injury and in human aortic smooth muscle cells. Approach and Results— From 2513 patients undergoing coronary artery intervention and follow-up angiography at ≈1 year, 262 patients were diagnosed with ISR, and 298 patients with no ISR were randomly included as controls. Serum HMGB2 levels were significantly higher in patients with ISR than in those without ISR and were associated with ISR severity. Multivariable logistic regression analysis showed that HMGB2 level was independently associated with ISR. In experiments, HMGB2 expression was increased in vascular tissue after injury. Perivascular HMGB2 administration promoted injury-induced neointimal hyperplasia in C57Bl/6 mice compared with in the control, whereas such pathophysiological features were attenuated in Hmgb2 –/– mice. Mechanistically, HMGB2 enhanced neointimal hyperplasia in mice and proliferation and migration in human aortic smooth muscle cells by inducing reactive oxygen species through increased p47phox phosphorylation. Knocking down p47phox, however, inhibited HMGB2-induced effects in human aortic smooth muscle cells. Finally, HMGB2-induced effects were significantly declined in receptor of advanced glycation end products knockdown or deficient cells, but not in Toll-like receptor 4 knockdown or deficient cells. Conclusions— Serum HMGB2 levels were associated with ISR in patients. HMGB2 promoted neointimal hyperplasia in mice with arterial wire injury through reactive oxygen species activation.
Databáze: OpenAIRE